332 related articles for article (PubMed ID: 15451453)
21. Progress toward gene therapy of Duchenne muscular dystrophy.
Hartigan-O'Connor D; Chamberlain JS
Semin Neurol; 1999; 19(3):323-32. PubMed ID: 12194388
[TBL] [Abstract][Full Text] [Related]
22. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
[TBL] [Abstract][Full Text] [Related]
23. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
Jooss K; Turka LA; Wilson JM
Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
[TBL] [Abstract][Full Text] [Related]
24. Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin.
Gilbert R; Dudley RW; Liu AB; Petrof BJ; Nalbantoglu J; Karpati G
Hum Mol Genet; 2003 Jun; 12(11):1287-99. PubMed ID: 12761044
[TBL] [Abstract][Full Text] [Related]
25. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice.
Yang L; Lochmuller H; Luo J; Massie B; Nalbantoglu J; Karpati G; Petrof BJ
Gene Ther; 1998 Mar; 5(3):369-79. PubMed ID: 9614557
[TBL] [Abstract][Full Text] [Related]
26. DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle.
Chen HH; Mack LM; Choi SY; Ontell M; Kochanek S; Clemens PR
Hum Gene Ther; 1999 Feb; 10(3):365-73. PubMed ID: 10048389
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.
Haegel-Kronenberger H; Haanstra K; Ziller-Remy C; Ortiz Buijsse AP; Vermeiren J; Stoeckel F; Van Gool SW; Ceuppens JL; Mehtali M; De Boer M; Jonker M; Boon L
Gene Ther; 2004 Feb; 11(3):241-52. PubMed ID: 14737083
[TBL] [Abstract][Full Text] [Related]
28. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm.
Petrof BJ; Acsadi G; Jani A; Massie B; Bourdon J; Matusiewicz N; Yang L; Lochmüller H; Karpati G
Am J Respir Cell Mol Biol; 1995 Nov; 13(5):508-17. PubMed ID: 7576685
[TBL] [Abstract][Full Text] [Related]
29. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
Todo T; Martuza RL; Dallman MJ; Rabkin SD
Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
[TBL] [Abstract][Full Text] [Related]
30. Effects of adenovirus-mediated gene transfer of ICOSIg and CTLA4Ig fusion protein on experimental autoimmune myocarditis.
Liu W; Gao C; Zhou BG; Li WM
Autoimmunity; 2006 Mar; 39(2):83-92. PubMed ID: 16698663
[TBL] [Abstract][Full Text] [Related]
31. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression.
Schowalter DB; Meuse L; Wilson CB; Linsley PS; Kay MA
Gene Ther; 1997 Aug; 4(8):853-60. PubMed ID: 9338015
[TBL] [Abstract][Full Text] [Related]
32. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome.
Thummala NR; Ghosh SS; Lee SW; Reddy B; Davidson A; Horwitz MS; Chowdhury JR; Chowdhury NR
Gene Ther; 2002 Aug; 9(15):981-90. PubMed ID: 12101428
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic gene transfer to dystrophic diaphragm by an adenoviral vector deleted of all viral genes.
Matecki S; Dudley RW; Divangahi M; Gilbert R; Nalbantoglu J; Karpati G; Petrof BJ
Am J Physiol Lung Cell Mol Physiol; 2004 Sep; 287(3):L569-76. PubMed ID: 15155269
[TBL] [Abstract][Full Text] [Related]
34. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
[TBL] [Abstract][Full Text] [Related]
35. In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes.
Haecker SE; Stedman HH; Balice-Gordon RJ; Smith DB; Greelish JP; Mitchell MA; Wells A; Sweeney HL; Wilson JM
Hum Gene Ther; 1996 Oct; 7(15):1907-14. PubMed ID: 8894682
[TBL] [Abstract][Full Text] [Related]
36. Transient blocking of both B7.1 (CD80) and B7.2 (CD86) in addition to CD40-CD40L interaction fully abrogates the immune response following systemic injection of adenovirus vector.
Ziller C; Stoeckel F; Boon L; Haegel-Kronenberger H
Gene Ther; 2002 May; 9(9):537-46. PubMed ID: 11973629
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of CD4+CD25+ T lymphocyte by adenovirus-mediated gene transfer of CTLA4Ig fusion protein in experimental autoimmune myocarditis.
Wei L; Wei-Min L; Cheng G; Bao-Guo Z
Autoimmunity; 2006 Jun; 39(4):289-98. PubMed ID: 16891217
[TBL] [Abstract][Full Text] [Related]
38. Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport.
Xiong F; Xiao S; Yu M; Li W; Zheng H; Shang Y; Peng F; Zhao C; Zhou W; Chen H; Fang L; Chamberlain JS; Zhang C
BMC Neurosci; 2007 Jul; 8():50. PubMed ID: 17617925
[TBL] [Abstract][Full Text] [Related]
39. Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route.
Cho WK; Ebihara S; Nalbantoglu J; Gilbert R; Massie B; Holland P; Karpati G; Petrof BJ
Hum Gene Ther; 2000 Mar; 11(5):701-14. PubMed ID: 10757350
[TBL] [Abstract][Full Text] [Related]
40. Systemic delivery of a high-capacity adenoviral vector expressing mouse CTLA4Ig improves skeletal muscle gene therapy.
Jiang Z; Feingold E; Kochanek S; Clemens PR
Mol Ther; 2002 Sep; 6(3):369-76. PubMed ID: 12231173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
